Protein family
Protein sequence
Protein function
Catalytic activity
EC number
EC number description
2.7.11.30
Transferases;
Transferring phosphorus-containing groups;
Protein-serine/threonine kinases;
receptor protein serine/threonine kinase
PDB | Resolution (Å) | PDB name |
---|---|---|
1B6C | 2.6 | CRYSTAL STRUCTURE OF THE CYTOPLASMIC DOMAIN OF THE TYPE I TGF-BETA RECEPTOR IN COMPLEX WITH FKBP12 |
1IAS | 2.9 | CYTOPLASMIC DOMAIN OF UNPHOSPHORYLATED TYPE I TGF-BETA RECEPTOR CRYSTALLIZED WITHOUT FKBP12 |
1PY5 | 2.3 | Crystal Structure of TGF-beta receptor I kinase with inhibitor |
1RW8 | 2.4 | Crystal Structure of TGF-beta receptor I kinase with ATP site inhibitor |
1VJY | 2.0 | Crystal Structure of a Naphthyridine Inhibitor of Human TGF-beta Type I Receptor |
2L5S | Solution structure of the extracellular domain of the TGF-beta type I receptor | |
2PJY | 3.0 | Structural basis for cooperative assembly of the TGF-beta signaling complex |
2WOT | 1.85 | ALK5 IN COMPLEX WITH 4-((5,6-dimethyl-2-(2-pyridyl)-3-pyridyl)oxy)-N-(3,4,5-trimethoxyphenyl)pyridin-2-amine |
2WOU | 2.3 | ALK5 IN COMPLEX WITH 4-((4-((2,6-dimethyl-3-pyridyl)oxy)-2-pyridyl) amino)benzenesulfonamide |
2X7O | 3.7 | Crystal structure of TGFbRI complexed with an indolinone inhibitor |
3FAA | 3.35 | Crystal structure of TGFbRI complexed with a 2-aminoimidazole inhibitor |
3GXL | 1.8 | ALK-5 kinase complex with GW857175 |
3HMM | 1.7 | Structure of Alk5 + GW855857 |
3KCF | 2.8 | Crystal structure of TGFbRI complexed with a pyrazolone inhibitor |
3KFD | 2.995 | Ternary complex of TGF-b1 reveals isoform-specific ligand recognition and receptor recruitment in the superfamily |
3TZM | 1.7 | TGF-beta Receptor type 1 in complex with SB431542 |
4X0M | 1.68 | Selection of fragments for kinase inhibitor design: decoration is key |
4X2F | 1.49 | Selection of fragments for kinase inhibitor design: decoration is key |
4X2G | 1.51 | Selection of fragments for kinase inhibitor design: decoration is key |
4X2J | 1.69 | Selection of fragments for kinase inhibitor design: decoration is key |
4X2K | 1.69 | Selection of fragments for kinase inhibitor design: decoration is key |
4X2N | 1.8 | Selection of fragments for kinase inhibitor design: decoration is key |
5E8S | 1.45 | TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (WT) |
5E8T | 1.7 | TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (T204D) |
5E8U | 2.03 | TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (T204D,I211V,Y249F,S280T, Y282F,S287N,A350C,L352F) |
5E8W | 1.86 | TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (T204D) IN COMPLEX WITH STAUROSPORINE |
5E8X | 1.45 | TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (T204D,I211V,Y249F,S280T, Y282F,S287N,A350C,L352F) IN COMPLEX WITH STAUROSPORINE |
5E8Z | 1.51 | TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (T204D) IN COMPLEX WITH 3-AMINO-6-[4-(2-HYDROXYETHYL)PHENYL]-N-[4-(MORPHOLIN-4-YL)PYRIDIN-3-YL]PYRAZINE-2-CARBOXAMIDE |
5E90 | 2.05 | TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (T204D,I211V,Y249F, S280T,Y282F,S287N,A350C,L352F) IN COMPLEX WITH 3-AMINO-6- [4-(2-HYDROXYETHYL)PHENYL]-N-[4-(MORPHOLIN-4-YL)PYRIDIN-3-YL]PYRAZINE-2-CARBOXAMIDE |
5FRI | 2.0 | ALK5 in complex witha an N-(4-anilino-2-pyridyl)acetamide inhibitor. |
5QIK | 1.58 | TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (T204D) IN COMPLEX WITH N-{4-[3-(6-fluoropyridin-3-yl)-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}acetamide |
5QIL | 1.98 | TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (T204D) IN COMPLEX WITH N-{4-[3-(6-METHOXYPYRIDIN-3-YL)-1H-PYRROLO[3,2-B]PYRIDIN-2-YL]PYRIDIN-2-YL}ACETAMIDE |
5QIM | 1.75 | TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (T204D) IN COMPLEX WITH N-{4-[3-(5-METHOXYPYRIDIN-2-YL)-1H-PYRROLO[3,2-B] PYRIDIN-2-YL]PYRIDIN-2-YL}ACETAMIDE |
5QTZ | 1.83 | TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (T204D) IN COMPLEX WITH 6-[1-(2,2-DIFLUOROETHYL)-4-(6-METHYLPYRIDIN-2-YL)-1H-IMIDAZOL-5-YL]IMIDAZO[1,2-A]PYRIDINE |
5QU0 | 1.67 | TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (T204D) IN COMPLEX WITH 6-[4-(3-CHLORO-4-FLUOROPHENYL)-1-(2-HYDROXYETHYL)-1H-IMIDAZOL-5-YL]IMIDAZO[1,2-B]PYRIDAZINE-3-CARBONITRILE |
5USQ | 2.55 | ALK-5 kinase inhibitor complex |
6B8Y | 1.65 | TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (T204D) IN COMPLEX WITH N-(3-fluoropyridin-4-yl)-2-[6-(trifluoromethyl)pyridin-2-yl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine |
6MAC | 2.34 | Ternary structure of GDF11 bound to ActRIIB-ECD and Alk5-ECD |
GO ontology | GO term | GO description |
---|---|---|
Biological Process | GO:0032924 | activin receptor signaling pathway |
Biological Process | GO:0060978 | angiogenesis involved in coronary vascular morphogenesis |
Biological Process | GO:0009952 | anterior/posterior pattern specification |
Biological Process | GO:0006915 | apoptotic process |
Biological Process | GO:0048844 | artery morphogenesis |
Biological Process | GO:0001824 | blastocyst development |
Biological Process | GO:0060317 | cardiac epithelial to mesenchymal transition |
Biological Process | GO:0048870 | cell motility |
Biological Process | GO:0071363 | cellular response to growth factor stimulus |
Biological Process | GO:0071560 | cellular response to transforming growth factor beta stimulus |
Biological Process | GO:0030199 | collagen fibril organization |
Biological Process | GO:0060982 | coronary artery morphogenesis |
Biological Process | GO:0048701 | embryonic cranial skeleton morphogenesis |
Biological Process | GO:0042118 | endothelial cell activation |
Biological Process | GO:0043542 | endothelial cell migration |
Biological Process | GO:0001935 | endothelial cell proliferation |
Biological Process | GO:1905223 | epicardium morphogenesis |
Biological Process | GO:0001837 | epithelial to mesenchymal transition |
Biological Process | GO:0043062 | extracellular structure organization |
Biological Process | GO:0046847 | filopodium assembly |
Biological Process | GO:0008354 | germ cell migration |
Biological Process | GO:0007507 | heart development |
Biological Process | GO:0001701 | in utero embryonic development |
Biological Process | GO:0035556 | intracellular signal transduction |
Biological Process | GO:0001822 | kidney development |
Biological Process | GO:0002088 | lens development in camera-type eye |
Biological Process | GO:0008584 | male gonad development |
Biological Process | GO:0048762 | mesenchymal cell differentiation |
Biological Process | GO:0032331 | negative regulation of chondrocyte differentiation |
Biological Process | GO:0001937 | negative regulation of endothelial cell proliferation |
Biological Process | GO:2001237 | negative regulation of extrinsic apoptotic signaling pathway |
Biological Process | GO:0007399 | nervous system development |
Biological Process | GO:0048663 | neuron fate commitment |
Biological Process | GO:0060017 | parathyroid gland development |
Biological Process | GO:0060389 | pathway-restricted SMAD protein phosphorylation |
Biological Process | GO:0018105 | peptidyl-serine phosphorylation |
Biological Process | GO:0018107 | peptidyl-threonine phosphorylation |
Biological Process | GO:0060037 | pharyngeal system development |
Biological Process | GO:0045893 | positive regulation of DNA-templated transcription |
Biological Process | GO:0043410 | positive regulation of MAPK cascade |
Biological Process | GO:0060391 | positive regulation of SMAD protein signal transduction |
Biological Process | GO:2001235 | positive regulation of apoptotic signaling pathway |
Biological Process | GO:0030307 | positive regulation of cell growth |
Biological Process | GO:0030335 | positive regulation of cell migration |
Biological Process | GO:0008284 | positive regulation of cell population proliferation |
Biological Process | GO:0001938 | positive regulation of endothelial cell proliferation |
Biological Process | GO:0010718 | positive regulation of epithelial to mesenchymal transition |
Biological Process | GO:1905007 | positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation |
Biological Process | GO:0051491 | positive regulation of filopodium assembly |
Biological Process | GO:0010628 | positive regulation of gene expression |
Biological Process | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation |
Biological Process | GO:0051897 | positive regulation of protein kinase B signaling |
Biological Process | GO:0051496 | positive regulation of stress fiber assembly |
Biological Process | GO:1905075 | positive regulation of tight junction disassembly |
Biological Process | GO:0009791 | post-embryonic development |
Biological Process | GO:0006468 | protein phosphorylation |
Biological Process | GO:0006355 | regulation of DNA-templated transcription |
Biological Process | GO:0060043 | regulation of cardiac muscle cell proliferation |
Biological Process | GO:0051726 | regulation of cell cycle |
Biological Process | GO:0010717 | regulation of epithelial to mesenchymal transition |
Biological Process | GO:0010468 | regulation of gene expression |
Biological Process | GO:0043393 | regulation of protein binding |
Biological Process | GO:0031396 | regulation of protein ubiquitination |
Biological Process | GO:0070723 | response to cholesterol |
Biological Process | GO:0060021 | roof of mouth development |
Biological Process | GO:0007165 | signal transduction |
Biological Process | GO:0001501 | skeletal system development |
Biological Process | GO:0048705 | skeletal system morphogenesis |
Biological Process | GO:0048538 | thymus development |
Biological Process | GO:0007179 | transforming growth factor beta receptor signaling pathway |
Biological Process | GO:0003223 | ventricular compact myocardium morphogenesis |
Biological Process | GO:0060412 | ventricular septum morphogenesis |
Biological Process | GO:0003222 | ventricular trabecula myocardium morphogenesis |
Biological Process | GO:0042060 | wound healing |
Molecular Function | GO:0005524 | ATP binding |
Molecular Function | GO:0070411 | I-SMAD binding |
Molecular Function | GO:0046332 | SMAD binding |
Molecular Function | GO:0048185 | activin binding |
Molecular Function | GO:0016361 | activin receptor activity, type I |
Molecular Function | GO:0046872 | metal ion binding |
Molecular Function | GO:0004672 | protein kinase activity |
Molecular Function | GO:0004674 | protein serine/threonine kinase activity |
Molecular Function | GO:0050431 | transforming growth factor beta binding |
Molecular Function | GO:0005024 | transforming growth factor beta receptor activity |
Molecular Function | GO:0005025 | transforming growth factor beta receptor activity, type I |
Molecular Function | GO:0005114 | type II transforming growth factor beta receptor binding |
Cellular Component | GO:0048179 | activin receptor complex |
Cellular Component | GO:0005923 | bicellular tight junction |
Cellular Component | GO:0009986 | cell surface |
Cellular Component | GO:0005768 | endosome |
Cellular Component | GO:0016020 | membrane |
Cellular Component | GO:0045121 | membrane raft |
Cellular Component | GO:0005634 | nucleus |
Cellular Component | GO:0005886 | plasma membrane |
Cellular Component | GO:0043235 | receptor complex |
Cellular Component | GO:0070021 | transforming growth factor beta ligand-receptor complex |
InterPro | InterPro name |
---|---|
IPR000333 | Ser/Thr protein kinase, TGFB receptor |
IPR000472 | Activin types I and II receptor domain |
IPR000719 | Protein kinase domain |
IPR003605 | GS domain |
IPR008271 | Serine/threonine-protein kinase, active site |
IPR011009 | Protein kinase-like domain superfamily |
IPR017441 | Protein kinase, ATP binding site |
IPR045860 | Snake toxin-like superfamily |
Pfam | Pfam name |
---|---|
PF00069 | Protein kinase domain |
PF01064 | Activin types I and II receptor domain |
PF08515 | Transforming growth factor beta type I GS-motif |
Reactome | Reactome Name | Node type | Reactome Root | Reactome Root Name |
---|---|---|---|---|
R-HSA-2173788 | Downregulation of TGF-beta receptor signaling | Leaf | R-HSA-162582 | Signal Transduction |
R-HSA-2173789 | TGF-beta receptor signaling activates SMADs | Internal node | R-HSA-162582 | Signal Transduction |
R-HSA-2173791 | TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | Leaf | R-HSA-162582 | Signal Transduction |
R-HSA-3304356 | SMAD2/3 Phosphorylation Motif Mutants in Cancer | Leaf | R-HSA-1643685 | Disease |
R-HSA-3645790 | TGFBR2 Kinase Domain Mutants in Cancer | Leaf | R-HSA-1643685 | Disease |
R-HSA-3656532 | TGFBR1 KD Mutants in Cancer | Leaf | R-HSA-1643685 | Disease |
R-HSA-3656535 | TGFBR1 LBD Mutants in Cancer | Leaf | R-HSA-1643685 | Disease |
R-HSA-5689603 | UCH proteinases | Leaf | R-HSA-392499 | Metabolism of proteins |
R-HSA-5689880 | Ub-specific processing proteases | Leaf | R-HSA-392499 | Metabolism of proteins |
Location | ECO term | Pubmed |
---|---|---|
Cell junction, tight junction | ECO:0000269 | PubMed:15761148 |
Cell membrane | ECO:0000269 | PubMed:21791611 |
Cell membrane | ECO:0000269 | PubMed:25893292 |
Cell membrane | ECO:0000269 | PubMed:9472030 |
Cell surface | ECO:0000269 | PubMed:25893292 |
Membrane raft | ECO:0000269 | PubMed:25893292 |
HPO ID | HPO name |
---|---|
HP:0000006 | Autosomal dominant inheritance |
HP:0000023 | Inguinal hernia |
HP:0000098 | Tall stature |
HP:0000175 | Cleft palate |
HP:0000193 | Bifid uvula |
HP:0000202 | Orofacial cleft |
HP:0000218 | High palate |
HP:0000238 | Hydrocephalus |
HP:0000272 | Malar flattening |
HP:0000278 | Retrognathia |
HP:0000316 | Hypertelorism |
HP:0000347 | Micrognathia |
HP:0000520 | Proptosis |
HP:0000525 | Abnormality iris morphology |
HP:0000577 | Exotropia |
HP:0000592 | Blue sclerae |
HP:0000766 | Abnormal sternum morphology |
HP:0000767 | Pectus excavatum |
HP:0000768 | Pectus carinatum |
HP:0000822 | Hypertension |
HP:0000951 | Abnormality of the skin |
HP:0000963 | Thin skin |
HP:0000965 | Cutis marmorata |
HP:0000977 | Soft skin |
HP:0000978 | Bruising susceptibility |
HP:0000987 | Atypical scarring of skin |
HP:0001065 | Striae distensae |
HP:0001083 | Ectopia lentis |
HP:0001162 | Postaxial hand polydactyly |
HP:0001166 | Arachnodactyly |
HP:0001249 | Intellectual disability |
HP:0001263 | Global developmental delay |
HP:0001297 | Stroke |
HP:0001363 | Craniosynostosis |
HP:0001373 | Joint dislocation |
HP:0001388 | Joint laxity |
HP:0001519 | Disproportionate tall stature |
HP:0001631 | Atrial septal defect |
HP:0001634 | Mitral valve prolapse |
HP:0001640 | Cardiomegaly |
HP:0001643 | Patent ductus arteriosus |
HP:0001647 | Bicuspid aortic valve |
HP:0001659 | Aortic regurgitation |
HP:0001677 | Coronary artery atherosclerosis |
HP:0001695 | Cardiac arrest |
HP:0001762 | Talipes equinovarus |
HP:0001763 | Pes planus |
HP:0001892 | Abnormal bleeding |
HP:0002105 | Hemoptysis |
HP:0002107 | Pneumothorax |
HP:0002138 | Subarachnoid hemorrhage |
HP:0002140 | Ischemic stroke |
HP:0002308 | Chiari malformation |
HP:0002326 | Transient ischemic attack |
HP:0002616 | Aortic root aneurysm |
HP:0002617 | Vascular dilatation |
HP:0002647 | Aortic dissection |
HP:0002650 | Scoliosis |
HP:0002664 | Neoplasm |
HP:0002705 | High, narrow palate |
HP:0002875 | Exertional dyspnea |
HP:0003549 | Abnormality of connective tissue |
HP:0003581 | Adult onset |
HP:0003621 | Juvenile onset |
HP:0004933 | Ascending aortic dissection |
HP:0004937 | Pulmonary artery aneurysm |
HP:0004942 | Aortic aneurysm |
HP:0004944 | Dilatation of the cerebral artery |
HP:0004950 | Peripheral arterial stenosis |
HP:0004959 | Descending thoracic aorta aneurysm |
HP:0005112 | Abdominal aortic aneurysm |
HP:0005116 | Arterial tortuosity |
HP:0005162 | Abnormal left ventricular function |
HP:0005182 | Bicuspid pulmonary valve |
HP:0005294 | Arterial dissection |
HP:0005692 | Joint hyperflexibility |
HP:0010646 | Cervical spine instability |
HP:0010648 | Dermal translucency |
HP:0011106 | Hypovolemia |
HP:0012163 | Carotid artery dilatation |
HP:0012385 | Camptodactyly |
HP:0012499 | Descending aortic dissection |
HP:0012763 | Paroxysmal dyspnea |
HP:0030745 | Dilatation of the ductus arteriosus |
HP:0100490 | Camptodactyly of finger |
HP:0100718 | Uterine rupture |
HP:0100749 | Chest pain |
HP:0100775 | Dural ectasia |
HP:0200146 | Mucoid extracellular matrix accumulation |
HP:0410151 | Eosinophilic infiltration of the esophagus |
Disease name | MONDO ID | ICD10 | ICD10 chapter | OMIM | Orphanet |
---|---|---|---|---|---|
ehlers-danlos syndrome, classic type | MONDO:0007522 | Q79 | chapter17, Congenital malformations, deformations and chromosomal abnormalities | Orphanet:287 | |
multiple self-healing squamous epithelioma | MONDO:0007566 | C44 | chapter2, Neoplasms | OMIM:132800 | Orphanet:65748 |
marfan syndrome | MONDO:0007947 | Q87 | chapter17, Congenital malformations, deformations and chromosomal abnormalities | OMIM:154700 | Orphanet:284963 |
marfan syndrome | MONDO:0007947 | Q87 | chapter17, Congenital malformations, deformations and chromosomal abnormalities | OMIM:154700 | Orphanet:558 |
loeys-dietz syndrome 1 | MONDO:0012212 | Q87 | chapter17, Congenital malformations, deformations and chromosomal abnormalities | OMIM:609192 | Orphanet:91387 |
loeys-dietz syndrome 1 | MONDO:0012212 | Q87 | chapter17, Congenital malformations, deformations and chromosomal abnormalities | OMIM:609192 | Orphanet:97295 |
familial thoracic aortic aneurysm and aortic dissection | MONDO:0019625 | I71 | chapter9, Diseases of the circulatory system | OMIMPS:607086 | Orphanet:91387 |
familial thoracic aortic aneurysm and aortic dissection | MONDO:0019625 | Q87 | chapter17, Congenital malformations, deformations and chromosomal abnormalities | OMIMPS:607086 | Orphanet:91387 |